Navigation Links
Januvia Lawsuits Consultations Now Offered by the Berman Law Group, Januvia Lawyers and Compensation Experts
Date:5/3/2013

New York, NY (PRWEB) May 03, 2013

The law offices of Berman and Berman are now representing clients who may have been affected or harmed by the diabetes drug Januvia. The partners of Berman and Berman will provide legal representation for clients across the United States who have taken Januvia, Sitagliptin, or any other form of the diabetic drug. They can be reached at their website: http://lawsuitjanuvia.com or by phone at 1-877-529-8995. They are able to represent clients all over the world who have been allegedly harmed from using the drug and want to file a Januvia lawsuit and pursue justice.

The Berman and Berman law group consists of personal injury attorneys who have built an esteemed reputation over time through their legal cases and fair representation of the clients they serve. The law firm is based in Florida but is able to represent clients throughout the United States who may have been severely injured from taking the drug Januvia.

Januvia (sitagliptin) is an oral diabetes medicine that helps control blood sugar levels. It works by regulating the levels of insulin your body produces after eating. Januvia is for people with type 2 diabetes. It is sometimes used in combination with other diabetes medications, but is not for treating type 1 diabetes. Januvia may also be used for purposes not listed in this medication guide. Januvia side effects include Upper respiratory tract infections, sore throat and runny or stuffy nose, headaches, swelling in the legs, feet, or hands, diarrhea, abdominal pain, nausea. More severe side effects include pancreatitis, little or no urinating, swelling, weight gain, feeling short of breath, or severe skin reactions. To read more about Januvia, visit this website: http://www.mayoclinic.com/health/drug-information/DR602203/. If anyone has experienced severe side effects while taking this drug, contact the Berman Law Group today to see if they may have a potential Januvia lawsuit claim at 1-877-529-8995

To contact the Law Offices of Berman and Berman and see options for filing a Januvia lawsuit case, call them at 1-877-529-8995 or visit their website where clients have 24 hour access to email, phone, and live chat on the website. Contact the Berman and Berman law group, where justice will be served for those who have been injured or wrongfully harmed.

Read the full story at http://www.prweb.com/releases/januvia/lawsuit-lawyers/prweb10701796.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
2. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
3. DrugRisk Announces Addition of Januvia Cancer Resource Center
4. Stryker Hip Lawsuits: Bernstein Liebhard LLP Notes Issuance of New Orders in New Jersey Stryker Rejuvenate and ABG II Litigation
5. NuvaRing Lawsuits Move Forward, as Federal Judge Rules that Plaintiffs’ Experts May Testify on “Bursts” of Estrogen Allegedly Delivered by NuvaRing, Wright & Schulte LLC
6. As Da Vinci Robot Lawsuits Mount, Bernstein Liebhard LLP Applauds Surgeon’s Call for More Stringent Robotic Surgery Training
7. Fosamax Lawsuits Update: Rottenstein Law Group Responds to Femur Fracture Verdict in Merck’s Favor
8. DePuy ASR Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Hip Recall Litigation
9. Mirena Lawsuits: Bernstein Liebhard LLP Disturbed by New Study Finding IUDs Safe for Teens, In Light of Alleged Mirena Complications
10. Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note Upcoming Conference in New Jersey Pelvic Mesh Implant Lawsuits
11. Yasmin, Yaz Alleged Blood-Clotting Lawsuits Update: Resource4thePeople Reports Bayer Settles Nearly 5,000 Cases for $1 Billion and also now Settling Gall Bladder Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... country’s leading private owners, developers and operators of commercial real estate proudly announced ... its 2015 Heart Health initiative. Team members portfolio-wide will continue Olshan Properties’ ...
(Date:5/4/2016)... MD (PRWEB) , ... May 04, 2016 , ... ... Ostomy and Continence Nurses (WOCN) Society™ and Canadian Association for Enterostomal Therapy ... event promotion, time saving and planning tools to attendees and exhibitors for the ...
(Date:5/4/2016)... Gilmer, TX (PRWEB) , ... May 04, 2016 ... ... commencement of a master charity program created to assist the people of their ... working closely with nonprofit organizations and community leaders. Their hope is to bring ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... 2016. SS&A teamed up with one of the top website design companies to ... contains informative legal articles related to the law firm's main practice areas. These ...
(Date:5/4/2016)... ... 2016 , ... Nordic Naturals announces another breakthrough innovation—Omega Curcumin, ... synergistic combination of omega-3 fatty acids and potent antioxidants contains 1000 mg concentrated ... and 200 mg of N-Acetylcysteine (NAC). , Each nutrient plays a distinct ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... 2016 According to market research ... Growth and Demand Forecast to 2022 - Industry Insights ... Field, Very High Field, Low to Mid Field, and ... Spine, Musculoskeletal, Vascular, Breast, Pelvic and Abdomen, Cardiac, and ... (MRI) market was valued at $5,351.7 million in 2015, ...
(Date:5/3/2016)... Norgine B.V. und ... entscheidenden Meilenstein durch diese Veröffentlichung zur  Hepatischen ... um Patientenresultate  bei Verdauungs- und Lebererkrankungen zu ... Verständnis der Hepatischen Enzephalopathie bei und hebt ... Enzephalopathie in der Öffentlichkeit zu schaffen und ...
(Date:5/2/2016)... 2016  Celsion Corporation (NASDAQ: CLSN ), ... from the first cohort of patients in its ... Study) combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... In the first three patients dosed, GEN-1 plus ...
Breaking Medicine Technology: